These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Metastatic papillary carcinoma of the thyroid in a patient previously treated for Graves' disease. Yunusa GH; Kotze T; Brink A Ann Afr Med; 2014; 13(2):91-4. PubMed ID: 24705115 [TBL] [Abstract][Full Text] [Related]
3. Time course of Graves' ophthalmopathy after total thyroidectomy alone or followed by radioiodine therapy: a 2-year longitudinal study. De Bellis A; Conzo G; Cennamo G; Pane E; Bellastella G; Colella C; Iacovo AD; Paglionico VA; Sinisi AA; Wall JR; Bizzarro A; Bellastella A Endocrine; 2012 Apr; 41(2):320-6. PubMed ID: 22169963 [TBL] [Abstract][Full Text] [Related]
4. [Graves' disease and papillary thyroid cancer--coincidence or association?]. Kinkel B; Bucerius J; Risse JH Dtsch Med Wochenschr; 2007 May; 132(18):983-6. PubMed ID: 17457781 [TBL] [Abstract][Full Text] [Related]
5. Unusual case of radioactive iodine-induced Graves' disease with orbitopathy following total thyroidectomy in a patient with papillary thyroid microcarcinoma. Zgubieński K; Walczyk A; Kowalska A Endokrynol Pol; 2020; 71(3):277-278. PubMed ID: 32293702 [TBL] [Abstract][Full Text] [Related]
6. Graves' ophthalmopathy after total thyroidectomy for papillary carcinoma. Giovansili L; Cayrolle G; Belange G; Clavel G; Herdan ML Ann Endocrinol (Paris); 2011 Feb; 72(1):42-4. PubMed ID: 21195999 [TBL] [Abstract][Full Text] [Related]
7. Use of methotrexate to treat isolated Graves ophthalmopathy developing years after thyroidectomy and iodine 131 treatment of papillary thyroid cancer. Sanyal P; Bing-You RG; Braverman LE Endocr Pract; 2008; 14(4):422-5. PubMed ID: 18558593 [TBL] [Abstract][Full Text] [Related]
8. Graves' disease and concurrent thyroid carcinoma. The importance of thyroid scintigraphy in Graves' disease. Joseph UA; Jhingran SG Clin Nucl Med; 1995 May; 20(5):416-8. PubMed ID: 7628144 [TBL] [Abstract][Full Text] [Related]
9. [A case of Graves-Basedow disease with orbitopathy and papillary thyroid cancer]. Bałdys-Waligórska A; Gołkowski F; Sokołowski G; Buziak-Bereza M; Skalski M; Hubalewska-Dydejczyk A Endokrynol Pol; 2008; 59(6):516-20. PubMed ID: 19347817 [TBL] [Abstract][Full Text] [Related]
10. Blocking the Thyrotropin Receptor with K1-70 in a Patient with Follicular Thyroid Cancer, Graves' Disease, and Graves' Ophthalmopathy. Ryder M; Wentworth M; Algeciras-Schimnich A; Morris JC; Garrity J; Sanders J; Young S; Sanders P; Furmaniak J; Rees Smith B Thyroid; 2021 Oct; 31(10):1597-1602. PubMed ID: 34114495 [No Abstract] [Full Text] [Related]
11. [Thyroid tuberculosis associated with papillary microcarcinoma of the thyroid gland: a case report]. el Kohen A; Essakalli L; Amarti A; Benchekroun L; Jazouli N; Kzadri M Rev Laryngol Otol Rhinol (Bord); 2001; 122(3):205-8. PubMed ID: 11799865 [TBL] [Abstract][Full Text] [Related]
12. [Analysis of the factors affecting the efficacy of (131)I remnant ablation in patients after thyroidectomy for papillary thyroid microcarcinoma]. Du F; Hu S; Wu C; Cheng Y; Wu LX; Liu JZ; Wu ZF; Li SJ Zhonghua Zhong Liu Za Zhi; 2018 Aug; 40(8):610-613. PubMed ID: 30139032 [No Abstract] [Full Text] [Related]
13. Thyroid-associated ophthalmopathy and TSH receptor autoantibodies in nonmetastatic thyroid cancer after total thyroidectomy. Antonelli A; Fallahi P; Tolari S; Ferrari SM; Ferrannini E Am J Med Sci; 2008 Sep; 336(3):288-90. PubMed ID: 18794628 [TBL] [Abstract][Full Text] [Related]
14. Aggressive behavior of papillary microcarcinoma in a patient with Graves' disease initially presenting as cystic neck mass. Braga M; Graf H; Ogata A; Batista J; Hakim NC J Endocrinol Invest; 2002 Mar; 25(3):250-3. PubMed ID: 11936468 [TBL] [Abstract][Full Text] [Related]
15. Recent outcome of Graves' disease patients with papillary thyroid cancer. Yano Y; Shibuya H; Kitagawa W; Nagahama M; Sugino K; Ito K; Ito K Eur J Endocrinol; 2007 Sep; 157(3):325-9. PubMed ID: 17766715 [TBL] [Abstract][Full Text] [Related]
16. Time course of Graves' orbitopathy after total thyroidectomy and radioiodine therapy for thyroid cancer. Louvet C; De Bellis A; Pereira B; Bournaud C; Kelly A; Maqdasy S; Roche B; Desbiez F; Borson-Chazot F; Tauveron I; Batisse-Lignier M Medicine (Baltimore); 2016 Nov; 95(48):e5474. PubMed ID: 27902601 [TBL] [Abstract][Full Text] [Related]
17. Treating the thyroid in the presence of Graves' ophthalmopathy. Hegedüs L; Bonnema SJ; Smith TJ; Brix TH Best Pract Res Clin Endocrinol Metab; 2012 Jun; 26(3):313-24. PubMed ID: 22632368 [TBL] [Abstract][Full Text] [Related]
18. A case of Graves' disease and papillary thyroid carcinoma with predominant production of thyroid-stimulation-blocking antibodies (TSBAb) persisted after total thyroidectomy. Nakamura S; Ishiyama-Takuno M; Kosaka J; Kondo K; Horiya Y; Hara S; Shima H; Shiraki T Endocrinol Jpn; 1992 Feb; 39(1):133-9. PubMed ID: 1351465 [TBL] [Abstract][Full Text] [Related]
19. Prevention of Orbitopathy by Oral or Intravenous Steroid Prophylaxis in Short Duration Graves' Disease Patients Undergoing Radioiodine Ablation: A Prospective Randomized Control Trial Study. Vannucchi G; Covelli D; Campi I; Currò N; Dazzi D; Rodari M; Pepe G; Chiti A; Guastella C; Lazzaroni E; Salvi M Thyroid; 2019 Dec; 29(12):1828-1833. PubMed ID: 31860407 [No Abstract] [Full Text] [Related]
20. Clinical Implications of Immunoglobulin G4 to Graves' Ophthalmopathy. Yu SH; Kang JG; Kim CS; Ihm SH; Choi MG; Yoo HJ; Lee SJ Thyroid; 2017 Sep; 27(9):1185-1193. PubMed ID: 28805160 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]